Trends in sarcoidosis mortality rate in Japan from 2001 to 2020: A population-based study

被引:8
作者
Harada, Ko [1 ,2 ]
Hagiya, Hideharu [2 ]
Koyama, Toshihiro [3 ]
Otsuka, Fumio [2 ]
机构
[1] Icahn Sch Med Mt Sinai, Dept Med, Mt Sinai Beth Israel, First Ave,16th St, New York, NY 10003 USA
[2] Okayama Univ, Dept Gen Med, Grad Sch Med Dent & Pharmaceut Sci, Okayama, Japan
[3] Okayama Univ, Dept Pharmaceut Biomed, Grad Sch Med Dent & Pharmaceut Sci, Okayama, Japan
基金
日本学术振兴会;
关键词
Sarcoidosis; Trend analysis; Sarcoidosis mortality rate; Geriatrics; Aging;
D O I
10.1016/j.rmed.2022.106828
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: The sarcoidosis mortality rate has increased over the years, which contributes to the health care burden. Although epidemiological studies of sarcoidosis mortality in aging societies are essential, none have been published since 1989 in Japan. Methods: We aimed to investigate the trends in crude and age-adjusted sarcoidosis-associated mortality rates per 1,000,000 population in Japan from 2001 to 2020 using national death certificate data among older adults aged over 50 years. The data were analysed using the joinpoint regression models to estimate long-term trends and average annual percentage changes (AAPCs). Results: A total of 3094 sarcoidosis-associated deaths were recorded from 2001 to 2020 in Japan; women constituted 65.3% of these, with a female:male ratio of 1.89. Nearly 80% of deaths were over the age of 65 years, of which 32% were over the age of 80 years. The trend in crude mortality of those aged >= 80 years markedly increased from 0.81 to 9.68 per 1,000,000 population in men and from 2.38 to 12.87 in women, respectively. The overall age-adjusted sarcoidosis mortality rate increased 2.46-fold during the study period, with an AAPC of 5.1%. Conclusions: This study revealed that sarcoidosis-associated deaths in Japan have significantly increased over the past two decades, especially among the older population with a female predominance. Given the rising mortality rate and susceptibility of the older population, sarcoidosis will require more attention from health care providers in terms of a multidisciplinary approach to address the specific needs of the older population.
引用
收藏
页数:5
相关论文
共 24 条
[1]  
[Anonymous], EUR RESPIR J, V14
[2]   Sarcoidosis incidence and prevalence: a nationwide register-based assessment in Sweden [J].
Arkema, Elizabeth V. ;
Grunewald, Johan ;
Kullberg, Susanna ;
Eklund, Anders ;
Askling, Johan .
EUROPEAN RESPIRATORY JOURNAL, 2016, 48 (06) :1690-1699
[3]  
Baughman RP, 2016, Ann Am Thorac Soc, V13, P1244
[4]   Do Death Certificates Underestimate the Burden of Rare Diseases? The Example of Systemic Lupus Erythematosus Mortality, Sweden, 2001-2013 [J].
Falasinnu, Titilola ;
Rossides, Marios ;
Chaichian, Yashaar ;
Simard, Julia F. .
PUBLIC HEALTH REPORTS, 2018, 133 (04) :481-488
[5]  
Gade Sikjaer Melina, RESP MED, V187
[6]   Disease Burden and Variability in Sarcoidosis [J].
Gerke, Alicia K. ;
Judson, Marc A. ;
Cozier, Yvette C. ;
Culver, Daniel A. ;
Koth, Laura L. .
ANNALS OF THE AMERICAN THORACIC SOCIETY, 2017, 14 :S421-S428
[7]   Morbidity and mortality in sarcoidosis [J].
Gerke, Alicia K. .
CURRENT OPINION IN PULMONARY MEDICINE, 2014, 20 (05) :472-478
[8]   Sarcoidosis [J].
Grunewald, Johan ;
Grutters, Jan C. ;
Arkema, Elizabeth V. ;
Saketkoo, Lesley Ann ;
Moller, David R. ;
Mueller-Quernheim, Joachim .
NATURE REVIEWS DISEASE PRIMERS, 2019, 5 (1)
[9]   Mortality trends in Asbestosis, Extrinsic Allergic Alveolitis and Sarcoidosis in England and Wales [J].
Hanley, A. ;
Hubbard, R. B. ;
Navaratnam, V. .
RESPIRATORY MEDICINE, 2011, 105 (09) :1373-1379
[10]  
IWAI K, 1993, ACTA PATHOL JAPON, V43, P372